CB1 antagonist 1

• Description:

  CB1 antagonist 1 is an antagonist of CB1 receptor, used in the research of metabolic syndrome and obesity, neuroinflammatory disorders, cognitive disorders and psychosis, gastrointestinal disorders, and cardiovascular conditions.

• UNSPSC:

  12352005

• Target:

  Cannabinoid Receptor

• Type:

  Reference compound

• Related Pathways:

  GPCR/G Protein; Neuronal Signaling

• Applications:

  Metabolism-protein/nucleotide metabolism

• Field of Research:

  Metabolic Disease; Inflammation/Immunology; Neurological Disease; Cardiovascular Disease

• Assay Protocol:

  https://www.medchemexpress.com/Benzonitrile,_3-chloro-4-[2-_4-chlorophenyl_-4-[1-_4-cyanophenyl_ethyl]-1-piperazinyl]-.html

• Solubility:

  10 mM in DMSO

• Smiles:

  N#CC1=CC=C(N2C(C3=CC=C(Cl)C=C3)CN(C(C4=CC=C(C#N)C=C4)C)CC2)C(Cl)=C1

• Molecular Formula:

  C26H22Cl2N4

• Molecular Weight:

  461.39

• References & Citations:

  [1]Gilbert, Eric J, et al. SUBSTITUTED PIPERAZINES AS CB1 ANTAGONISTS. WO 2006060461 A1.

• Shipping Conditions:

  Room temperature

• Scientific Category:

  Reference compound1

• Clinical Information:

  No Development Reported

• CAS Number:

  890037-68-0